Report on China's Anti-fungal Drug IndustrySunFAITH China Ltd.December 13, 2006 20 Pages - SKU: CJFQ1421805 |
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs)
3/2/2012 | published by: Kalorama Information
Point of Care Diagnostics represents one of the highest-growth industries in testing. This bundle allows Kalorama Information customers to save by purchasing one PDF which contains our most popular previously published reports on point-of-care
|
more...
|
$3,995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
4/20/2012 | published by: Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces
|
more...
|
$28,700.00
|
|
2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
4/20/2012 | published by: Venture Planning Group
This report presents a comprehensive analysis of the German infectious disease testing market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market
|
more...
|
$5,900.00
|
|
Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
3/23/2012 | published by: GBI Research
Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion Summary GBI Research, the leading business intelligence provider, has released its latest research “Anti-Hypertensives Market to 2017 -
|
more...
|
$3,500.00
|
|
West and Central Africa Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
BMI View: The better regulated markets of the Gulf Cooperation Council (GCC), South Africa and Israelwill remain the most rewarding and least risky for drugmakers operating in the Middle East and Africa(MEA). However, these markets
|
more...
|
$1,175.00
|
|
China Pharmaceutical Industry Research and Forecast to 2016
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The present report on “China Pharmaceutical Industry Research and Forecast to 2016” analyzes in detail the pharmaceutical industry environment with market sizing in terms of patented drugs, generic drugs, OTC drug and even sub-segments
|
more...
|
$700.00
|
|
Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation
2/29/2012 | published by: GlobalData
Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation Summary The report is an essential source of information and analysis on the KALYDECO (ivacaftor, VX-770) for the treatment of Cystic Fibrosis (CF) patients with
|
more...
|
$500.00
|
|
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
3/21/2012 | published by: IBISWorld
Brand Name Pharmaceutical Manufacturing in the US Prescription for growth With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience a surge in demand. The expansion of biosimilar drugs will
|
more...
|
$910.00
|
Related Markets
Dermatology Reports
- Alopecia Global Clinical Trials Review, H1, 2012
- Botulinum Toxin
- World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
- Analytical Tool - Melanoma
- Dermatological Drugs: World Market Prospects 2012-2022
